Cora Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$831K Sell
3,401
-146
-4% -$34K 0.28% 50
2025
Q4
$734K Buy
3,547
+373
+12% +$73.8K 0.29% 51
2025
Q3
$588K Sell
3,174
-42
-1% -$7.2K 0.25% 57
2025
Q2
$491K Buy
3,216
+217
+7% +$33.4K 0.22% 59
2025
Q1
$497K Buy
2,999
+5
+0.2% +$782 0.24% 64
2024
Q4
$433K Sell
2,994
-1,236
-29% -$192K 0.21% 66
2024
Q3
$685K Sell
4,230
-19
-0.4% -$3.03K 0.34% 52
2024
Q2
$621K Buy
4,249
+325
+8% +$48.3K 0.32% 52
2024
Q1
$621K Buy
3,924
+476
+14% +$75.8K 0.33% 51
2023
Q4
$540K Buy
3,448
+185
+6% +$28.4K 0.32% 56
2023
Q3
$508K Sell
3,263
-594
-15% -$98K 0.34% 51
2023
Q2
$638K Buy
3,857
+81
+2% +$13.1K 0.42% 46
2023
Q1
$585K Buy
3,776
+142
+4% +$22.9K 0.44% 42
2022
Q4
$642K Buy
+3,634
New +$627K 0.44% 39

Other funds holding JNJ

Cora Capital Advisors's JNJ Position: Q1 2026 in Review

Cora Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 4.1% in Q1 2026, selling an estimated $34K and leaving 3,401 shares worth $831K. The position accounts for 0.28% of the portfolio, ranked #50.

Cora Capital Advisors first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cora Capital Advisors held 3,401 shares of Johnson & Johnson worth $831K as of Q1 2026.
  • Cora Capital Advisors sold 146 Johnson & Johnson shares in Q1 2026, an estimated $34K.
  • Johnson & Johnson made up 0.28% of Cora Capital Advisors's portfolio in Q1 2026, its #50 holding.
  • Cora Capital Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cora Capital Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.